Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
CNCR
63
HOLDINGS
nan%
ALSO IN CANC
CANC
51
HOLDINGS
0%
ALSO IN CNCR
SECTOR DRIFT (CNCR minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CNCR |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
CNCR Overweight Relative to CANC
| AUTOLUS THERAPEUTICS PLC SPONSORED A | -0.2% | |
| GRAIL INC | -0.3% | |
| ORIC PHARMACEUTICALS INC | -0.4% | |
| XENCOR INC | -0.4% | |
| REPLIMUNE GROUP, INC. | -0.5% | |
| SCHRODINGER, INC. | -0.5% | |
| ANAPTYSBIO, INC. | -0.5% | |
| IOVANCE BIOTHERAPEUTICS INC | -0.5% | |
| CORVUS PHARMACEUTICALS, INC. | -0.5% | |
| ARCUS BIOSCIENCES, INC. | -0.6% |
CNCR Underweight Relative to CANC
| REVOLUTION MEDICINES, INC. | -7.0% | |
| ELI LILLY & CO | -5.3% | |
| ROCHE HOLDINGS LTD-SPONS ADR | -4.2% | |
| NOVARTIS AG | -4.2% | |
| GENMAB A/S SPONSORED ADR | -4.1% | |
| ASTRAZENECA PLC | -4.1% | |
| BRIDGEBIO PHARMA, INC. | -3.9% | |
| ARCELLX, INC. | -3.7% | |
| NUVALENT, INC. CLASS A | -3.7% | |
| EXELIXIS INC | -3.0% |